BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 17044646)

  • 1. [Myrislignan Induces Apoptosis in Gastric Cancer Cell Line Through PI3K/AKT Signaling Pathway].
    Zhou YJ; Pan YY; Yang LJ; Bie MJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):136-141. PubMed ID: 36647656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zerumbone suppresses IKKα, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells.
    Weng HY; Hsu MJ; Wang CC; Chen BC; Hong CY; Chen MC; Chiu WT; Lin CH
    J Biomed Sci; 2012 Oct; 19(1):86. PubMed ID: 23035900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits bile acid-induced gastric intestinal metaplasia via the PI3K/AKT/p-FoxO4 signalling pathway.
    Lu W; Ni Z; Jiang S; Tong M; Zhang J; Zhao J; Feng C; Jia Q; Wang J; Yao T; Ning H; Shi Y
    Phytother Res; 2021 Mar; 35(3):1495-1507. PubMed ID: 33103284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
    Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H
    Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse roles of FOXO family members in gastric cancer.
    Chen YH; Li CL; Chen WJ; Liu J; Wu HT
    World J Gastrointest Oncol; 2021 Oct; 13(10):1367-1382. PubMed ID: 34721771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis.
    Street CA; Bryan BA
    Anticancer Res; 2011 Nov; 31(11):3645-57. PubMed ID: 22110183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells.
    Street CA; Routhier AA; Spencer C; Perkins AL; Masterjohn K; Hackathorn A; Montalvo J; Dennstedt EA; Bryan BA
    Int J Oncol; 2010 Nov; 37(5):1297-305. PubMed ID: 20878077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by L-NMMA, via FKHRL1/ROCK pathway in human gastric cancer cells.
    Wang YZ; Feng ZQ
    Biomed Environ Sci; 2006 Aug; 19(4):285-91. PubMed ID: 17044646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells.
    Radisavljevic Z
    Cancer; 2003 Mar; 97(5):1358-63. PubMed ID: 12599246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells.
    Zheng WH; Kar S; Quirion R
    J Biol Chem; 2000 Dec; 275(50):39152-8. PubMed ID: 10995739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons.
    Zheng WH; Kar S; Quirion R
    Mol Pharmacol; 2002 Aug; 62(2):225-33. PubMed ID: 12130673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.
    Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y
    Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.